Madison-based Stratatech Corp. announced that it has been awarded another federal grant, this one worth $154,000 from the National Institute of Aging to continue development of its genetically engineered human skin substitutes to speed the healing of chronic skin ulcers such as bed sores.
….Stratatech’s products are based on a patented, unique source of pathogen-free human skin cells identified at UW-Madison as being able to multiply indefinitely.